Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChronVac-C + SOC in Chronic Hepatitis C
NCT01335711Phase 2Unknown
- Sponsor
- ChronTech Pharma AB
- Start
- Apr 2011
- Primary completion
- Jun 2012
- Modality
- Prophylactic Vaccines, DNA Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of chronvac-c in hepatitis C (HCV), sponsored by ChronTech Pharma AB. Status: unknown.
02
Drugs
chronvac-c
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01335711.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01335711.